Patient Monitoring during Treatment with Ocrelizumab and Rituximab (ORP-49)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Nazanin Razazian

• View Article

Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mahshid Mahyad; Mohammad Ali Nahayati; Maryam Ebrahimian

• View Article